Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Phosphate | HCID 1061 | — |
| Reactant | NADP nicotinamide-adenine-dinucleotide phosphate | HCID 5886 | — |
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal | HCID 107526 | — |
| Reactant | Methyl 4-bromo-3-oxobutanoate | HCID 295655 | — |
| Solvent | Butyl Acetate | HCID 31272 | — |
| Product | Methyl 4-bromo-3-oxobutanoate | HCID 295655 | — |
| Product | Methyl 4-bromo-3-hydroxybutanoate | HCID 9855736 | — |
Reaction Steps
Methyl 4-bromo-3-oxobutyrate (300 mg), the above-mentioned wet bacterial cells (0.4 g), NADP+ (9 mg), glucose (750 mg), glucose dehydrogenase (manufactured by Amano Pharmaceuticals, Co., Ltd.) (1.2 mg), 100 mM phosphate buffer (pH 6.5) (15 ml) and butyl acetate (15 ml) were mixed. The mixture was stirred at 30° C. for 7 hr. During the stirring, 2M aqueous sodium carbonate solution was gradually added to adjust the pH of the reaction solution to 6.5±0.2. After the stirring had been finished, the reaction solution was centrifuged (1000×g, 5 min) to collect the organic layer. The organic layer was subjected to an analysis for content using gas chromatography under the following condition. Methyl 4-bromo-3-hydroxybutyrate was produced 98.5% to the amount of the methyl 4-bromo-3-oxobutyrate used in the reaction. Furthermore, the optical purity of methyl 4-bromo-3-hydroxybutyrate in the organic layer was measured at the following condition, which resulted in 99% e.e. of (S)-form. The organic layer was concentrated to give crude methyl (S)-4-bromo-3-hydroxybutyrate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07163814B2 |
|---|
| Source dataset | uspto-grants-2007_01 |
|---|
| ORD ID | ord-e289f9f443da4c6783c5426206f6b335 |
|---|
| Source note | uspto-grants-2007_01 |
|---|